HROW
Price
$36.99
Change
+$0.79 (+2.18%)
Updated
Sep 5 closing price
Capitalization
1.37B
71 days until earnings call
RMTI
Price
$1.62
Change
-$0.06 (-3.57%)
Updated
Sep 5 closing price
Capitalization
55.78M
71 days until earnings call
Interact to see
Advertisement

HROW vs RMTI

Header iconHROW vs RMTI Comparison
Open Charts HROW vs RMTIBanner chart's image
Harrow
Price$36.99
Change+$0.79 (+2.18%)
Volume$355.52K
Capitalization1.37B
Rockwell Medical
Price$1.62
Change-$0.06 (-3.57%)
Volume$1.91M
Capitalization55.78M
HROW vs RMTI Comparison Chart in %
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. RMTI commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a StrongBuy and RMTI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (HROW: $36.99 vs. RMTI: $1.62)
Brand notoriety: HROW and RMTI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HROW: 66% vs. RMTI: 146%
Market capitalization -- HROW: $1.37B vs. RMTI: $55.78M
HROW [@Pharmaceuticals: Generic] is valued at $1.37B. RMTI’s [@Pharmaceuticals: Generic] market capitalization is $55.78M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, HROW is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 5 TA indicator(s) are bullish while RMTI’s TA Score has 6 bullish TA indicator(s).

  • HROW’s TA Score: 5 bullish, 4 bearish.
  • RMTI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RMTI is a better buy in the short-term than HROW.

Price Growth

HROW (@Pharmaceuticals: Generic) experienced а -5.15% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was -5.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

HROW is expected to report earnings on Nov 17, 2025.

RMTI is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($1.37B) has a higher market cap than RMTI($55.8M). HROW YTD gains are higher at: 10.253 vs. RMTI (-20.588). HROW has higher annual earnings (EBITDA): 32.1M vs. RMTI (1.23M). HROW has more cash in the bank: 53M vs. RMTI (18.4M). RMTI has less debt than HROW: RMTI (14M) vs HROW (231M). HROW has higher revenues than RMTI: HROW (228M) vs RMTI (88M).
HROWRMTIHROW / RMTI
Capitalization1.37B55.8M2,453%
EBITDA32.1M1.23M2,603%
Gain YTD10.253-20.588-50%
P/E RatioN/AN/A-
Revenue228M88M259%
Total Cash53M18.4M288%
Total Debt231M14M1,650%
FUNDAMENTALS RATINGS
HROW vs RMTI: Fundamental Ratings
HROW
RMTI
OUTLOOK RATING
1..100
2728
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
49100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
4238
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (47) in the Medical Specialties industry is somewhat better than the same rating for HROW (83) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew somewhat faster than HROW’s over the last 12 months.

HROW's Profit vs Risk Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for RMTI (100) in the Medical Specialties industry. This means that HROW’s stock grew somewhat faster than RMTI’s over the last 12 months.

RMTI's SMR Rating (95) in the Medical Specialties industry is in the same range as HROW (96) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to HROW’s over the last 12 months.

RMTI's Price Growth Rating (38) in the Medical Specialties industry is in the same range as HROW (42) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to HROW’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for RMTI (100) in the Medical Specialties industry. This means that HROW’s stock grew significantly faster than RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWRMTI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWEIX49.400.11
+0.22%
MFS Global Equity I
PRMTX176.200.15
+0.09%
T. Rowe Price Comm & Tech Investor
BKRDX8.46N/A
N/A
iShares Developed Real Estate Idx K
HNIDX14.71N/A
N/A
Harbor Diversified Intl All Cp Retire
SDFSX18.53-0.05
-0.27%
Sit Small Cap Dividend Growth S

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with OGI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+2.18%
OGI - HROW
34%
Loosely correlated
+2.48%
AQST - HROW
34%
Loosely correlated
+7.11%
TKNO - HROW
33%
Poorly correlated
+2.83%
AMRX - HROW
32%
Poorly correlated
+0.73%
EBS - HROW
30%
Poorly correlated
-0.66%
More

RMTI and

Correlation & Price change

A.I.dvisor tells us that RMTI and AVDL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RMTI and AVDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
-3.57%
AVDL - RMTI
33%
Poorly correlated
+5.14%
EVOK - RMTI
28%
Poorly correlated
-1.51%
HROW - RMTI
28%
Poorly correlated
+2.18%
AKBA - RMTI
27%
Poorly correlated
-1.99%
EBS - RMTI
27%
Poorly correlated
-0.66%
More